Is it time to consider oral vancomycin treatment for the management of pediatric inflammatory bowel disease irrespective of the presence of primary sclerosing cholangitis?

2026-04-01

PRE

Gasparetto, Marco *

DOI：10.1002/jpn3.70431

Original request for help

Save

Abstract

Keywords:

immunosuppression

liver

microbiome

IF:

2.6

Papers:

250

Citations:

1.4W

Scholars:

345

Papers: 205

Citations: 6.9K

Scholars:

597

Papers: 291

Citations: 2.4K